NCT03375827View on ClinicalTrials.gov

Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

April 29, 2019

Study Completion Date

April 29, 2019

Conditions
Breast Cancer
Interventions
OTHER

IGCDG

The IGCDG reviews topics of concern for patients with metastatic breast cancer.

Trial Locations (1)

02115

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT03375827 - Feasibility of an Individualized Goals of Care Discussion Guide for Advanced Breast Cancer | Biotech Hunter | Biotech Hunter